You have 9 free searches left this month | for more free features.

Condition

Cutaneous Melanoma (1)

Mucosal Melanoma (1)

Uveal Melanoma (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Hoffmann-La Roche (1)

Collaborator

Intervention

adalimumab (1)

obinutuzumab (1)

ro7293583 (1)

tocilizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

ro7293583

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cutaneous Melanoma, Uveal Melanoma, Mucosal Melanoma Trial in Worldwide (RO7293583, Tocilizumab, Obinutuzumab)

Completed

Cutaneous Melanoma
+2 more

RO7293583
+3 more

Boston, Massachusetts
+13 more

Sep 30, 2022